China NMPA E2B(R3) Best Practices Frequently asked questions 13 Frequently asked questions This chapter contains the most frequently asked questions about NMPA. Can the OOTB Argus E2B(R3) NMPA profile be used to submit post-marketed and clinical trial ICSRs to NMPA? What should you consider when sending the EDQM terms in Route of Administration and Dosage Formulation elements?